Press Releases

HIV+Hep estimates HIV cases averted & cost savings due to long-acting PrEP

“We must make sure that everyone with a reason to be on PrEP is able to access the medication best suited to their needs. With new long-acting PrEP, many people who have had a hard time adhering to a regimen of a daily pill now have another option to prevent HIV,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “And we now know that more cases of HIV can be averted and medical costs can be saved by gradually increasing the uptake of long-acting PrEP. This must be taken into account as we develop policies and programs regarding the use and coverage of PrEP.”

read more

Federal civil rights office gives pass to insurer for HIV discrimination

“While it is reassuring that OCR formally investigated our complaint, the harm to people living with HIV has been going on for years. This was blatant discriminatory plan design and the entities charged with enforcing ACA’s patient protections let Blue Cross Blue Shield North Carolina off with not even a slap on the wrist,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “This is further proof that insurers are allowed to get away with as much as they can. And even when they are caught, there is no penalty. For insurance to work for people living with HIV and all patients, we need better federal and state regulation, oversight, and enforcement.”

read more

With Court victories, patient groups drop appeal in copay assistance case

“Now that the court has struck down the rule that allowed insurers and PBMs not to count copay assistance and clarified that the previous rule—requiring copay assistance to count in most instances—is now in effect, we now must turn to enforcement to ensure patients are no longer being financially harmed by copay accumulators,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, one of the plaintiffs in the lawsuit. “We are already hearing from patients that insurers are still subjecting them to these unscrupulous and now, illegal practices, and we will ensure that any unlawful practices stop.”

read more

Government drops appeal in copay assistance case

“We are pleased that the government has withdrawn its appeal of our court victory for patients who struggle to afford their prescription drugs and rely on copay assistance,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, one of the plaintiffs in the lawsuit. “Now, insurers must heed the court ruling by ending their cruel policy of collecting copay assistance and not applying it to patients’ cost-sharing obligations.”

read more

Pin It on Pinterest